Shexiang Baoxin Pill, a Proprietary Multi-Constituent Chinese Medicine, Prevents Locomotor and Cognitive Impairment Caused by Brain Ischemia and Reperfusion Injury in Rats: A Potential Therapy for Neuropsychiatric Sequelae of Stroke
Ischemic stroke is a common type of cerebrovascular event and also the leading cause of disability. Post-stroke cognitive impairment occurs frequently in stroke survivors. Shexiang Baoxin Pill (SBP) is a proprietary Chinese medicine, initially used to treat cardiovascular diseases. Herein, we aim to...
Main Authors: | Zong-Shi Qin, Yu Zheng, Xi-Dan Zhou, Dong-Dong Shi, Dan Cheng, Chun Shum Shek, Chang-Sen Zhan, Zhang-Jin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.665456/full |
Similar Items
-
Exploring the pathways and targets of Shexiang Baoxin pill for coronary heart disease through a network pharmacology approach
by: Shou-De Zhang, et al.
Published: (2018-01-01) -
Co-administration of Shexiang Baoxin Pill and Chemotherapy Drugs Potentiated Cancer Therapy by Vascular-Promoting Strategy
by: Liu-qing Yang, et al.
Published: (2019-05-01) -
Shexiang Baoxin Pill, a Traditional Chinese Herbal Formula, Rescues the Cognitive Impairments in APP/PS1 Transgenic Mice
by: Wei-Hui Hu, et al.
Published: (2020-07-01) -
Shexiang Baoxin Pill, Derived From the Traditional Chinese Medicine, Provides Protective Roles Against Cardiovascular Diseases
by: Li Lu, et al.
Published: (2018-11-01) -
Shexiang Baoxin Pill Corrects Metabolic Disorders in a Rat Model of Metabolic Syndrome by Targeting Mitochondria
by: Dan Wei, et al.
Published: (2018-03-01)